CIK: 0001668029 · Show all filings
Period: Q1 2021 (← Previous) (Next →)
Filing Date: Sep 17, 2021
Total Value ($000): $38,313 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| AVIR | ATEA PHARMACEUTICALS INC | 300,000 | $18,525 | 48.4% | $32.23 | +109.6% | COM | 04683R106 |
| LUNG | PULMONX CORP | 303,030 | $13,861 | 36.2% | $48.97 | +17.1% | COM | 745848101 |
| — | ABG ACQUISITION CORP I | 501,300 | $4,958 | 12.9% | $9.89 | — | CL A SHS | G00496102 |
| — | AEGLEA BIOTHERAPEUTICS INC | 112,044 | $887 | 2.3% | $7.87 | — | COM | 00773J103 |
| — | DIFFUSION PHARMACEUTICALS IN | 89,848 | $82 | 0.2% | $0.79 | — | COM PAR | 253748305 |